Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials

7 Jun 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to Cellular Mechanics and Interactions
Share to Cytokine Signaling Pathways and Interactions

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29908439
DOI: 10.1016/j.ejmech.2018.06.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trialsPMID 29908439Read ↗

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVIDSemantic proximity Read ↗

Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitationsSemantic proximity Read ↗

Will kinase inhibitors have a dark side?Semantic proximity Read ↗

Cell biology. Lessons in rational drug design for protein kinases.Semantic proximity Read ↗

Kinase domain mutations in cancer: implications for small molecule drug design strategies.Semantic proximity Read ↗

Unraveling the mysterious veil of ULK1: From non-canonical functions to therapeutic applicationsSemantic proximity Read ↗

Polypharmacology is an enduring and nearly universal property of kinase inhibitorsSemantic proximity Read ↗

A New Challenging and Promising Era of Tyrosine Kinase InhibitorsSemantic proximity Read ↗

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future PerspectivesSemantic proximity Read ↗

Do fourth-generation EGFR inhibitors showcase the future of kinase inhibitors?Semantic proximity Read ↗

LIM kinases: function, regulation and association with human diseaseSemantic proximity Read ↗

[Kinase inhibitors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.